The Deep Mining Era: Genomic, Metabolomic, and Integrative Approaches to Microbial Natural Products from 2018 to 2024
Marine Drugs · 23.06.2025 · 23 (7) · 261
DOI: 10.3390/md23070261 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 23.06.2025. Verfasst von Zhaochao Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Techn…. Hauptthemen laut MEDLINE: Biological Products, Metabolomics, Genomics, Data Mining. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project of International Cooperation and Exchanges NSFC-ASRT, Key Research and Development Program of Zhejiang Province.
Abstract (Originalsprache)
Over the past decade, microbial natural products research has witnessed a transformative “deep-mining era” driven by key technological advances such as high-throughput sequencing (e.g., PacBio HiFi), ultra-sensitive HRMS (resolution ≥ 100,000), and multi-omics synergy. These innovations have shifted discovery from serendipitous isolation to data-driven, targeted mining. These innovations have transitioned discovery from serendipitous isolation to data-driven targeted mining. Genome mining pipelines (e.g., antiSMASH 7.0 and DeepBGC) can now systematically discover hidden biosynthetic gene clusters (BGCs), especially in under-explored taxa. Metabolomics has achieved unprecedented accuracy, enabling researchers to target novel compounds in complex extracts. Integrated strategies—combining genomic prediction, metabolomics analysis, and experimental validation—constitute new paradigms of current “deep mining”. This review provides a systematic overview of 185 novel microbial natural products discovered between 2018 and 2024, and dissects how these technological leaps have reshaped the discovery paradigm from traditional isolation to data-driven mining.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China.
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
ORCID-Profile: Hong Wang, Jianwei Chen
Förderung
- National Natural Science Foundation of China
- Project of International Cooperation and Exchanges NSFC-ASRT
- Key Research and Development Program of Zhejiang Province
- National Key Research and Development Program of China
- the National Key Research and Development Program of China
- the Project of International Cooperation and Exchanges NSFC-ASRT
- the National Natural Science Foundation of China
- the Key Research and Development Program of Zhejiang Province
Zitieren
APA
Wang, Z., Yu, J., Wang, C., Hua, Y., Wang, H., & Chen, J. (2025). The Deep Mining Era: Genomic, Metabolomic, and Integrative Approaches to Microbial Natural Products from 2018 to 2024. Marine Drugs, 23(7), 261. https://doi.org/10.3390/md23070261
Vancouver
Wang Z, Yu J, Wang C, Hua Y, Wang H, Chen J. The Deep Mining Era: Genomic, Metabolomic, and Integrative Approaches to Microbial Natural Products from 2018 to 2024. Marine Drugs. 2025;23(7):261. doi:10.3390/md23070261
BibTeX
@article{Wang2025,
author = {Wang, Zhaochao and Yu, Juanjuan and Wang, Chenjie and Hua, Yi and Wang, Hong and Chen, Jianwei},
title = {The Deep Mining Era: Genomic, Metabolomic, and Integrative Approaches to Microbial Natural Products from 2018 to 2024},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {7},
pages = {261},
doi = {10.3390/md23070261}
}
EUVIMED